Context Therapeutics is a startup based in the United States, 1 tracked investor.
Based in the United States, Context Therapeutics is a startup. Brouky records 1 investor associated with the company.
Context Therapeutics develops next-generation bispecific T cell engager antibody therapies targeting solid tumors to harness the immune system for cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.